**[미래에셋 제약/바이오 김승민]**
**10/1 Daily**

[https://t.me/bioksm](https://t.me/bioksm)


 **글로벌 바이오/제약**
────────────────────
 [릴리의 실험용 병용약(아밀린+젭바운드), 젭바운드를 체중감량 임상에서 상회](https://news.google.com/rss/articles/CBMivAFBVV95cUxPd091UFNjZjRoTng5cVJCUXRNblZ0ZnBOR2xtUlhXN3lEQUtkUGtGZTBRdk11SnhCT1N0WTVFYVIwNmZMeUd6RzZiSmNxMHVWdHlORDhIWDdnVjJVc2lMTTQwdERSZVYwTG5JUlpwQWxna1JDRl9fWHZIdTh3QUhYaEdITW5lczgyVnp1aTZDcVdkdVRKeGZjeTNGU1luRUJGQUYwMUwyckdVdFdIOGhYOVNYV0VTd1ZiZVlhTg?oc=5)

 [머크의 실험용 피부질환 약물 Tulisokibart, 임상 2상 성공](https://news.google.com/rss/articles/CBMi3gFBVV95cUxNX2dneUVmM2V6anN4UXpfRGFJdW1qb3Y4N2d4bXh5SWNDRkRtTWIyZ1FXMjJrbDhJYWgtVXAtWjZ0cjdTUFNqN1RicUhFTXUtN1ZmbnZiNjZqVjJLRkJBTmRqUVVlWTZ2Nk45OFFPV0JFSVEyQVZEc2ctLUFVVDcwZE9QVVRDdTFGYTR3RUFDX2RpQUQ0cmhXakQ4bWQwT2xtZ3VUR0hFVTlaczA0NWFhZk1JYkRiU0xuY1hxZzZSMWZySDBIYU42cTFoV3ZWRWRCS1NjNjRKQVVHaVpITkE?oc=5)

 [EASD26: 로슈·질랜드의 아밀린 임상 데이터 공개 - 중용량 이후 체중감량 곡선 정체](https://news.google.com/rss/articles/CBMiU0FVX3lxTE9BTjVIcWFudEtUbUV4SnBMWGxlcjZZc1U4Zk9BU2tDejZndjM5cDloV2Y5STNiMEE0NHRCMDdNV1NZTG1tV3VfaTNOa1g0dFBuWWx3?oc=5)

 [릴리 EBGLYSS (레브리키주맙), 중등도-중증 수부 아토피 피부염 3b상에서 피부 개선 및 가려움증 완화 입증](https://investor.lilly.com/news-releases/news-release-details/new-phase-3b-data-show-lillys-ebglyss-lebrikizumab-lbkz)

 [노보노디스크 Wegovy 경구약, 주사제에서 전환한 환자의 체중감량 증대](https://news.google.com/rss/articles/CBMixwFBVV95cUxOV2FUY2RMMFhZbG1TbklKV0ZGUnRMU3VvRTk2RHExTEV6QVlnSVdMT2h6bFhoN3NDT1VFekJjUmVVUUJVMTViNDdwcWlMdXIxZ0hiZ0tDeFo1Z1dwVHlkWkhBY3ppRGVXeHhXTDFGdVNjZnZyYW0tcVg5NGdITmJDTXVhNy0yLURsM2JuRlhqaURZUUFKd2JHNnZ5ZkIycEE5YndnSFdoYXBVNUhhbVlHVE11dFZyM0tidVU1dmloZ2lDaGtrbThN?oc=5)

 [로슈, 3개 유전질환 신생아 선별검사 제품 출시](https://news.google.com/rss/articles/CBMijgJBVV95cUxPRzk2U1RoVU11VEhTanZScUZ2RzRBU1F6OUFmOEFZQkhkS1I0UVVZbzh4TExqTFIzRVk2enJjWTctUmR1NHh4c1Q2c3g3c2JNcTVYMDhlaVZMMG9kdXBKelk5OFJ4YU05X3JqbXpQcjNhcHczUzZuWUwxOV9jLUN4R2k3a3VabFFma3htVEN0bEpRYzd1YWl0RW5iX3hYT292bE1VZUZCTjBibnBiTWNsblpjcUZKLWRqZ2JoUnhtWkJrYlFKdUFjTXpMU1RzUkxCLTh0aHFYQXYtc1FVUnVvdlFJVnRXQk8yWGZTcDUxUHdyRThYOENhLXlVRmZlTmo1ZG5FV295UmthNGl1YUE?oc=5)


 **한국 바이오/제약**
────────────────────
 [리가켐바이오, 에이비온 iADC 타깃 독점 기술도입](https://www.hitnews.co.kr/news/articleView.html?idxno=79536)

 [일동제약, 아이디언스 367억원 규모 투자](https://www.hitnews.co.kr/news/articleView.html?idxno=79542)

 [알지노믹스·라이보텍, 차세대 RNA 교정 플랫폼 공동연구 협약](https://www.hitnews.co.kr/news/articleView.html?idxno=79515)

 [아리바이오, 우회상장 무산](https://news.google.com/rss/articles/CBMiWkFVX3lxTE1zV3V2bDlKcFB2UTgtWXZ3V3o5QUVEQVFtcGF0Rm1TUDN3TW81YVlGTEtqdVJNbnJPcWtDcFV2dGtQcHhTcC10NDRTRzhEclBHcE5NMTcwUmpUQQ?oc=5)

 [랩지노믹스, 위장관 검사 'LDT' 美 뉴저지주 보건부 승인](https://www.hitnews.co.kr/news/articleView.html?idxno=79514)

 [네오이뮨텍 'NT-I7' 기술이전 파트너, 日 타나베파마 항체 도입](https://news.google.com/rss/articles/CBMiWkFVX3lxTFAyZk5GcklNTVpOUWlTdk5la0QyeExQdkN1MWpONUE5dHZxWVVvUDB5eXlCajhKU0daZ1ZqajY2Z0ZuUHZ4ZkQwUW1pQ19hM2dEbjZoalF5dmw2dw?oc=5)

 [한국MSD, 내달부터 '키트루다 피하주사' 국내 공급](https://www.hitnews.co.kr/news/articleView.html?idxno=79520)


────────────────────